ZIVO ZIVO Bioscience, Inc. Stock Quote

ZIVO [NASD]

Index	-	P/E	-	EPS (ttm)	-1.06	Insider Own	8.60%	Shs Outstand	9.42M	Perf Week	-2.89%
Market Cap	26.20M	Forward P/E	-	EPS next Y	-0.83	Insider Trans	14.81%	Shs Float	6.25M	Perf Month	-14.60%
Income	-9.00M	PEG	-	EPS next Q	-0.22	Inst Own	5.00%	Short Float	1.73%	Perf Quarter	-22.03%
Sales	-	P/S	-	EPS this Y	33.00%	Inst Trans	-9.65%	Short Ratio	8.38	Perf Half Y	-18.24%
Book/sh	0.49	P/B	5.49	EPS next Y	27.20%	ROA	-92.60%	Target Price	9.00	Perf Year	-73.93%
Cash/sh	0.68	P/C	3.97	EPS next 5Y	-	ROE	-139.50%	52W Range	2.37 - 10.40	Perf YTD	-6.27%
Dividend	-	P/FCF	-	EPS past 5Y	19.80%	ROI	-	52W High	-74.13%	Beta	0.20
Dividend %	-	Quick Ratio	2.50	Sales past 5Y	-	Gross Margin	-	52W Low	13.60%	ATR	0.19
Employees	10	Current Ratio	2.50	Sales Q/Q	-	Oper. Margin	-	RSI (14)	33.44	Volatility	6.94% 6.29%
Optionable	No	Debt/Eq	0.17	EPS Q/Q	49.50%	Profit Margin	-	Rel Volume	0.10	Prev Close	2.61
Shortable	Yes	LT Debt/Eq	0.00	Earnings	-	Payout	-	Avg Volume	12.92K	Price	2.69
Recom	2.00	SMA20	-12.15%	SMA50	-21.75%	SMA200	-21.20%	Volume	1,229	Change	3.06%

Apr-25-22 04:05PM	Zivo Bioscience Regains Compliance Following Receipt of Noncompliance Notice from Nasdaq Business Wire
Jan-10-22 05:00PM	ZIVO Bioscience Names Chairman John B. Payne as President and CEO Business Wire +11.07%
Oct-06-21 10:10AM	Zivo Bioscience, Inc. to Participate in the Global AgTech Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest on October 14, 2021 at 10 A.M. EDT GlobeNewswire
Oct-05-21 12:57PM	Weblink Instructions for the Annual Meeting of Shareholders of Zivo Bioscience, Inc. GlobeNewswire
Sep-24-21 11:35AM	Amazon Event 2021: 5 New Product Predictions That Could Be Coming Sept. 28 InvestorPlace +57.97%
11:04AM	ZIVO Stock: 6 Things to Know About Biotech ZIVO Bioscience as Shares Rocket on No News InvestorPlace
Aug-17-21 04:05PM	Zivo Bioscience, Inc. Issues Letter to Shareholders GlobeNewswire
Aug-16-21 08:30AM	Keynotes, Educational Panels and 60 Companies to Present at the SNN Network Summer Virtual Event on August 17-19, 2021 ACCESSWIRE -5.08%
Aug-11-21 08:00AM	Zivo Bioscience to Present at Two Upcoming August Conferences GlobeNewswire
07:00AM	ZIVO Bioscience to Present at the Q3 Virtual Investor Summit Newsfile
Jul-02-21 08:00AM	Zivo Bioscience, Inc. Announces Closing of Underwriters Partial Exercise of Over-Allotment Option in Connection with its Previously Announced Public Offering GlobeNewswire
Jun-02-21 09:30AM	ZIVO Bioscience to Present at the LD Micro Virtual Invitational Conference on June 9, 2021 GlobeNewswire
09:05AM	Zivo Bioscience, Inc. Announces Closing of Upsized $13.8 Million Public Offering and Uplisting to Nasdaq GlobeNewswire
May-27-21 08:42PM	Zivo Bioscience, Inc. Announces Pricing of Upsized $13.8 Million Public Offering and Up-listing to Nasdaq GlobeNewswire -6.98%
Apr-26-21 12:06PM	ZIVO Bioscience Announces US Patent Office Notice of Allowance for Administration of Proprietary Algal Biomass to Support Immune Health GlobeNewswire +6.78%
Mar-11-21 12:25PM	ZIVO Bioscience to Participate in Maxim Groups Inaugural Emerging Growth Virtual Conference GlobeNewswire
Jan-11-21 02:50PM	ZIVO Bioscience Successfully Confirms Poultry Growth Promotion and Feed Conversion Ratio Improvements in Typical Production Environments ACCESSWIRE
Jan-07-21 04:35PM	Zivo Bioscience Names Keith R. Marchiando as Chief Financial Officer ACCESSWIRE +6.19%
Jul-13-20 08:00AM	Zivo Bioscience Releases Positive Results From Recent Poultry Trial ACCESSWIRE
Jun-09-20 08:30AM	ZIVO Bioscience Receives Notice of Allowance for Cytokine Modulation Patent Application From US Patent Office, Commences Bioproduct Scaleup ACCESSWIRE

ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. It operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is based in Keego Harbor, Michigan.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Maggiore Christopher D.	Director	Feb 11	Buy	3.87	44,965	173,952	803,105	Feb 16 06:02 AM
Maggiore Christopher D.	Director	Feb 10	Buy	3.63	18,006	65,452	758,140	Feb 16 06:02 AM
Maggiore Christopher D.	Director	Feb 09	Buy	3.55	28,363	100,694	740,134	Feb 16 06:02 AM
PAYNE JOHN BERNARD	Director	Jan 27	Buy	2.50	46	115	9,344	Jan 28 05:39 PM
PAYNE JOHN BERNARD	Director	Jan 25	Buy	2.50	9,122	22,805	9,298	Jan 28 05:39 PM
Maggiore Christopher D.	Director	Jan 11	Buy	2.64	7,560	19,956	711,771	Jan 14 05:48 PM
Masterson Nola E	Director	Jun 02	Buy	4.99	400	1,996	4,898	Jun 04 03:53 PM
Cornell Alison A	Director	Jun 02	Buy	4.99	15,000	74,850	15,000	Jun 04 03:49 PM
Maggiore Christopher D.	Director	Jun 02	Buy	4.99	100,000	499,000	704,211	Jun 04 03:44 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience